BioCentury
ARTICLE | Financial News

Epic raises $13 million in series B

November 14, 2012 2:28 AM UTC

Cancer diagnostic company Epic Sciences Inc. (La Jolla, Calif.) raised $13 million in a series B round. New investors Domain Associates; Roche Venture Fund; and Pfizer Venture Investments participated along with existing individual investors. Domain's Kim Kamdar will join Epic's board. ...